Amazon foregrounds consumer AI with its new health-improvement wearable

Trotting out a new digital health assistant this week, Amazon is emphasizing the wearable’s incorporation of AI to guide users toward some complicated goals.

These include reducing body mass index (BMI) and experiencing less stress by speaking more positively.

To the world, the device will look like a watchband minus the watch. That’s because the hardware faces the wearer’s wrist.

The band’s sleek circular appearance when it’s not being worn may explain why the Big Tech megaretailer is calling the product—a combo of app, sensor panel and wristband—the Halo.

In fact, the name refers to two parts. Halo itself is a mobile app while Halo Band is what you wear.

As for the sophisticated uses of AI, the Halo supplies users with feedback and guidance across five named health indices. The idea behind “Activity” and “Sleep” are self-explanatory.

But, as explained in Amazon blog posts, “Body” uses AI to image and track BMI by taking full-body photos on a smartphone, while “Tone” taps AI to give feedback on tone of voice.

The other section, “Labs,” designs and measures performance on workouts, challenges and the like.

In an Amazon press release, the product receives an endorsement from Eduardo Sanchez, MD, MPH, chief medical officer for prevention at the American Heart Association, which shared data with Amazon during Halo product development.

“Through our Center for Health Technology and Innovation, we [at the AHA] are pleased to provide our evidence-based science as part of this solution, which we believe has the potential to drive behavior change towards healthier lives,” Sanchez says.

Amazon is selling the package at an “early access” price of $64.99.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.